BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31893170)

  • 1. Eosinophilic Airway Inflammation in Patients with Stable Biomass Smoke- versus Tobacco Smoke-Associated Chronic Obstructive Pulmonary Disease.
    Fernandes L; Rane S; Mandrekar S; Mesquita AM
    J Health Pollut; 2019 Dec; 9(24):191209. PubMed ID: 31893170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative Systemic Biomarkers of Biomass Smoke-Induced Chronic Obstructive Pulmonary Disease among Women in a Rural South Indian Population.
    Vishweswaraiah S; Thimraj TA; George L; Krishnarao CS; Lokesh KS; Siddaiah JB; Larsson K; Upadhyay S; Palmberg L; Anand MP; Ganguly K
    Dis Markers; 2018; 2018():4949175. PubMed ID: 30595762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ongoing airway inflammation in patients with COPD who do not currently smoke.
    Rutgers SR; Postma DS; ten Hacken NH; Kauffman HF; van Der Mark TW; Koëter GH; Timens W
    Thorax; 2000 Jan; 55(1):12-8. PubMed ID: 10607796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
    Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial load and defective monocyte-derived macrophage bacterial phagocytosis in biomass smoke-related COPD.
    Ghosh B; Gaike AH; Pyasi K; Brashier B; Das VV; Londhe JD; Juvekar S; Shouche YS; Donnelly LE; Salvi SS; Barnes PJ
    Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30578387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The success and safety profile of sputum induction in patients with chronic obstructive pulmonary disease: An Indian experience.
    Fernandes L; Mesquita AM
    Indian J Tuberc; 2017 Jul; 64(3):201-205. PubMed ID: 28709489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
    Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
    [No Abstract]   [Full Text] [Related]  

  • 8. Sputum Biomarkers in Wood and Tobacco Smoke Etiotypes of Chronic Obstructive Pulmonary Disease.
    Giraldo-Montoya ÁM; Torres-Duque CA; Giraldo-Cadavid LF; Laucho-Contreras ME; González-Flórez A; Santos AM; Tuta-Quintero EA; Celli BR; González-García M
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1-10. PubMed ID: 38179428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomass smoke COPD has less tomographic abnormalities but worse hypoxemia compared with tobacco COPD.
    Meneghini AC; Koenigkam-Santos M; Pereira MC; Tonidandel PR; Terra-Filho J; Cunha FQ; Menezes MB; Vianna EO
    Braz J Med Biol Res; 2019; 52(5):e8233. PubMed ID: 31038579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Secretoglobin Family 1A Member 1 (SCGB1A1) Levels as a Marker of Biomass Smoke Induced Chronic Obstructive Pulmonary Disease.
    Veerapaneni VV; Upadhyay S; Thimraj TA; Siddaiah JB; Krishnarao CS; Lokesh KS; Thimmulappa R; Palmberg L; Ganguly K; Anand MP
    Toxics; 2021 Aug; 9(9):. PubMed ID: 34564359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
    Perng DW; Huang HY; Chen HM; Lee YC; Perng RP
    Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic airway inflammation in COPD.
    Saha S; Brightling CE
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):39-47. PubMed ID: 18046901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
    Olloquequi J; Jaime S; Parra V; Cornejo-Córdova E; Valdivia G; Agustí À; Silva O R
    Respir Res; 2018 Jan; 19(1):13. PubMed ID: 29347936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
    van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
    Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke.
    Cho J; Lee CH; Hwang SS; Kim KU; Lee SH; Park HY; Park SJ; Min KH; Oh YM; Yoo KH; Jung KS;
    BMC Pulm Med; 2019 Mar; 19(1):68. PubMed ID: 30902075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
    Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F
    Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
    Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
    Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
    Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.